Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · Real-Time Price · USD
3.310
-0.080 (-2.36%)
At close: Oct 6, 2026, 4:00 PM EDT
3.320
+0.010 (0.30%)
After-hours: Oct 6, 2026, 7:11 PM EDT
Ardelyx Market Cap
Ardelyx has a market cap or net worth of $824.81 million as of October 6, 2026. Its market cap has decreased by -34.93% in one year.
Market Cap
824.81M
Enterprise Value
825.49M
1-Year Change
-34.93%
Ranking
Category
Stock Price
$3.31
ChartMarket Cap Chart
Since June 19, 2014, Ardelyx's market cap has increased from $242.70M to $824.81M, an increase of 239.85%. That is a compound annual growth rate of 10.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 824.80M | -41.77% |
| Dec 31, 2025 | 1.42B | 17.95% |
| Dec 31, 2024 | 1.20B | -16.56% |
| Dec 29, 2023 | 1.44B | 169.38% |
| Dec 30, 2022 | 534.30M | 330.89% |
| Dec 31, 2021 | 124.00M | -78.76% |
| Dec 31, 2020 | 583.90M | 23.68% |
| Dec 31, 2019 | 472.10M | 324.55% |
| Dec 31, 2018 | 111.20M | -64.55% |
| Dec 29, 2017 | 313.70M | -53.30% |
| Dec 30, 2016 | 671.70M | 42.82% |
| Dec 31, 2015 | 470.30M | 34.29% |
| Dec 31, 2014 | 350.20M | 44.29% |
| Jun 19, 2014 | 242.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SL Science Holding | 866.80M |
| Rigel Pharmaceuticals | 861.33M |
| Jade Biosciences | 852.84M |
| Monte Rosa Therapeutics | 842.04M |
| Ginkgo Bioworks Holdings | 835.69M |
| SpyGlass Pharma | 828.84M |
| Sana Biotechnology | 823.24M |
| Obsidian Therapeutics | 816.64M |